Clinical Trial Update: Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating whether domperidone improves time-in-range for glucose in people with Type 1 diabetes and delayed gastric emptying (gastroparesis). The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis
• Type 1 Diabetes Mellitus

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Type 1 Diabetic | Phase 3 | Status: NOT_YET_RECRUITING